Autophagy: an emerging target for cancer therapy

Maria Høyer-Hansen1, Marja Jäättelä

  • 1Apoptosis Department, Centre for Genotoxic Stress Research, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.

Autophagy
|March 26, 2008
PubMed

Insights

Autophagy, a cellular recycling process, aids cell survival but paradoxically suppresses tumor formation. This review explores the complex role of autophagy in cancer, highlighting its therapeutic potential.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Macroautophagy (autophagy) is a fundamental cellular process for recycling macromolecules and organelles.
  • Autophagy is crucial for maintaining cellular metabolism during starvation and removing damaged components during stress, thereby promoting cell survival.
  • Emerging evidence suggests autophagy plays a suppressive role in tumorigenesis, presenting a complex dichotomy.

Purpose of the Study:

  • To review current understanding of autophagy's dual role in cell survival and death.
  • To highlight alterations in autophagy observed in cancer.
  • To discuss autophagy-related signaling pathways as potential targets for cancer therapy.

Main Methods:

  • Literature review of recent data on autophagy and cancer.
  • Synthesis of knowledge on autophagy-mediated control of cell fate.
  • Analysis of cancer-associated changes in autophagy pathways.

Main Results:

  • Autophagy generally promotes cell survival but can also contribute to cell death.
  • Cancer cells frequently exhibit altered autophagy induction, regulation, and execution.
  • Both pro- and anti-autophagic pathways present potential therapeutic targets.

Conclusions:

  • Autophagy's role in cancer is multifaceted, acting as both a tumor suppressor and a survival mechanism for cancer cells.
  • Understanding the molecular basis of autophagy's complex role is critical for developing novel cancer treatments.
  • Targeting autophagy pathways offers promising avenues for future cancer therapy.

Related Concept Videos

Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...